First human tests of Alzheimer's vaccine show promise
NCT ID NCT06831812
Summary
This early-stage study tested whether a new vaccine called AV-1959R is safe for healthy adults aged 40-60. Sixteen participants received either the vaccine or a placebo injection to check for side effects and measure immune response. The goal is to see if the vaccine can safely trigger the body to produce antibodies against proteins linked to Alzheimer's disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arvax
Adelaide, Australia
Conditions
Explore the condition pages connected to this study.